GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » Investments And Advances

Mesoblast (Mesoblast) Investments And Advances : $0.83 Mil (As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Mesoblast Investments And Advances?

Mesoblast's Investments And Advances for the quarter that ended in Dec. 2023 was $0.83 Mil.

Mesoblast's quarterly Investments And Advances declined from Jun. 2023 ($1.76 Mil) to Sep. 2023 ($0.00 Mil) but then increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.83 Mil).

Mesoblast's annual Investments And Advances declined from Jun. 2021 ($2.08 Mil) to Jun. 2022 ($1.76 Mil) and declined from Jun. 2022 ($1.76 Mil) to Jun. 2023 ($1.76 Mil).

Mesoblast Investments And Advances Historical Data

The historical data trend for Mesoblast's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesoblast Investments And Advances Chart

Mesoblast Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.32 1.87 2.08 1.76 1.76

Mesoblast Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 1.76 - 0.83 -

Mesoblast Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Mesoblast (Mesoblast) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mesoblast Ltd (OTCPK:MEOBF) » Definitions » Investments And Advances
Comparable Companies
ASX:CU6 ASX:CUV ASX:IMU ASX:IMM ASX:OPT ASX:PYC ASX:BOT ASX:RAC ASX:DXB ASX:PIQ OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
MESO:USA LWB:Germany MSB:Australia
Address
Level 38, 55 Collins Street, Melbourne, VIC, AUS, 3000
Website
https://www.mesoblast.com
Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.